Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays von Deben, Christophe, Cardenas De La Hoz, Edgar, Rodrigues Fortes, Felicia, Le Compte, Maxim, Seghers, Sofie, Vanlanduit, Steve, Vercammen, Hendrik, Van Den Bogert, Bert, Dusetti, Nelson, Lin, Abraham, Roeyen, Geert, Peeters, Marc, Prenen, Hans, Lardon, Filip, Smits, Evelien

Volltext

CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles von Terrones, Marc, Deben, Christophe, Rodrigues-Fortes, Felicia, Schepers, Anne, de Beeck, Ken Op, Van Camp, Guy, Vandeweyer, Geert

Volltext

Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition von Deben, Christophe, Boullosa, Laurie Freire, Fortes, Felicia Rodrigues, De La Hoz, Edgar Cardenas, Le Compte, Maxim, Seghers, Sofie, Peeters, Marc, Vanlanduit, Steve, Lin, Abraham, Dijkstra, Krijn K, Van Schil, Paul, Hendriks, Jeroen M H, Prenen, Hans, Roeyen, Geert, Lardon, Filip, Smits, Evelien

Volltext

Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer von Le Compte, Maxim, De La Hoz, Edgar Cardenas, Peeters, Sofía, Fortes, Felicia Rodrigues, Hermans, Christophe, Domen, Andreas, Smits, Evelien, Lardon, Filip, Vandamme, Timon, Lin, Abraham, Vanlanduit, Steve, Roeyen, Geert, Van Laere, Steven, Prenen, Hans, Peeters, Marc, Deben, Christophe

Volltext

Additional file 1 of CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resis... von Terrones, Marc, Deben, Christophe, Rodrigues-Fortes, Felicia, Schepers, Anne, de Beeck, Ken Op, Van Camp, Guy, Vandeweyer, Geert

Volltext bestellen